Sun Pharma Strikes $11.75 Billion Organon Deal in India’s Biggest Pharma Acquisition
Mumbai — Sun Pharmaceutical Industries will acquire U.S.-based drugmaker Organon & Co in an all-cash deal valued at about $11.75
Read More
Factual Version of a Story
obesity drugs
Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs
Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading
Read More
Novo Nordisk Nears Completion of Global Restructuring, Poised for Stronger Growth Ahead
Novo Nordisk’s global transformation plan, including the restructuring of its workforce, is nearly complete, signaling the company’s focus on innovation,
Read More